Draft Genetic Testing Policies
Blue Cross and Blue Shield of Alabama partners with Carelon Medical Benefits Management to administer genetic testing solutions for our members.
Carelon is our business associate and is an independent company that provides diagnostic testing, information and services. Carelon has agreed to follow our privacy and security policies regarding the confidentiality and protection of personal health information.
Note: Coverage is subject to the member's specific benefits. Group-specific policies will supersede these policies when applicable. Please refer to the member's benefit plan.
Draft Genetic Testing Policies
As part of the Carelon guideline annual review process, the below updates are focused on advancing efforts to drive clinically appropriate, safe, and affordable healthcare services.
Effective for dates of service on and after November 17, 2024, the changes in the document below will apply to the Carelon Medical Benefits Management Genetic Testing Clinical Appropriateness Guidelines.
Draft Imaging Policies
Clicking "Accept" will take you to a website operated by Carelon Medical Benefits Management.
Comment on Draft Policies
To ensure that the development of medical policies occurs through an open, collaborative process, we welcome comments about medical policies that are in the draft stage.
Participating providers are invited to submit scientific, evidence-based information, professional consensus opinions and other information supported by medical literature relevant to these draft policies for consideration.
Comments are accepted for 45 days from the posting date listed on the draft policy.
Make sure your voice is heard by providing feedback directly to us:
- Complete our online medical policy feedback form, or
- Send comments by mail or fax to:
Blue Cross and Blue Shield of Alabama
Attn: Health Management - Medical Policy
P.O. Box 995
Birmingham, AL 35298-0001
Fax: 205-220-0878